Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist.

Literature DB >> 8293832

Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist.

P D Silva¹, H E Perkins, C W Schauberger.

Abstract

A patient with a 10-year history of secondary infertility underwent GnRH-a therapy with LA for 5 months to control symptoms of severe adenomyosis and to avoid an unwanted hysterectomy. Shortly after cessation of treatment, the patient conceived. A healthy male was delivered at term by cesarean section, which makes this the first report of a live birth after treatment of severe adenomyosis with a GnRH-a.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Leuprolide

Year: 1994 PMID： 8293832 DOI： 10.1016/s0015-0282(16)56471-1

Source DB: PubMed Journal: Fertil Steril ISSN： 0015-0282 Impact factor: 7.329

Keyword Cloud
Cited

16 in total

1. An unexpected diagnosis of adenomyosis in the subfertile woman.

Authors: Tia Hunjan; Andrew Davidson
Journal: BMJ Case Rep Date: 2015-02-27

2. Management of adenomyosis in subfertile women and pregnancy outcome.

Authors: Fathia E Al Jama
Journal: Oman Med J Date: 2011-05

3. Does Adenomyosis Influence ICSI Clinical Outcome? A Systematic Analysis and Impact of GnRH Agonist Pretreatment for Women with Adenomyosis in ICSI-FET Cycle: A Retrospective Cohort Study.

Authors: Pradeepa Sudhakar; Saranya Manivannan; Dhanabagyam Kandasamy; Kavitha Jayapal
Journal: J Obstet Gynaecol India Date: 2021-06-24

Review 4. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors: G L Plosker; R N Brogden
Journal: Drugs Date: 1994-12 Impact factor: 9.546

5. Pituitary suppression before frozen embryo transfer is beneficial for patients suffering from idiopathic repeated implantation failure.

Authors: Xing Yang; Rui Huang; Yan-Fang Wang; Xiao-Yan Liang
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2016-02-03

10. Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment.

Authors: Chan Woo Park; Min Hye Choi; Kwang Moon Yang; In Ok Song
Journal: Clin Exp Reprod Med Date: 2016-09-22

Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist.

1. An unexpected diagnosis of adenomyosis in the subfertile woman.

2. Management of adenomyosis in subfertile women and pregnancy outcome.

3. Does Adenomyosis Influence ICSI Clinical Outcome? A Systematic Analysis and Impact of GnRH Agonist Pretreatment for Women with Adenomyosis in ICSI-FET Cycle: A Retrospective Cohort Study.

Review 4. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

5. Pituitary suppression before frozen embryo transfer is beneficial for patients suffering from idiopathic repeated implantation failure.

6. Infertility and adenomyosis.

Review 7. The Impact of Adenomyosis on Women's Fertility.

8. Clinical outcomes of infertility treatment for women with adenomyosis in Japan.

9. Transcriptome analysis of endometrial tissues following GnRH agonist treatment in a mouse adenomyosis model.

10. Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment.